Pekka Anttila
- Hematology top 5%
- Multiple Myeloma Research and Treatments 19
- Platelet Disorders and Treatments 3
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Hemoglobinopathies and Related Disorders 4
-
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 6
-
- Protein Degradation and Inhibitors 8
- Cancer therapeutics and mechanisms 3
- Co-authors
- Eeva JuvonenRaija SilvennoinenKalevi OksanenTapani RuutuEsko IkkalaCaroline A. HeckmanMuntasir Mamun MajumderNina N. Nupponen
- Cited by
- HematologyGeneticsOncology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)PLoS ONE (1 paper)
In The Last Decade
Pekka Anttila
30 papers receiving 382 citations
Peers
Comparison fields: 5 of 65
- Hematology 261
- Genetics 132
- Oncology 129
- Molecular Biology 244
- Rheumatology 36
Countries citing papers authored by Pekka Anttila
This map shows the geographic impact of Pekka Anttila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pekka Anttila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pekka Anttila more than expected).
Fields of papers citing papers by Pekka Anttila
This network shows the impact of papers produced by Pekka Anttila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pekka Anttila. The network helps show where Pekka Anttila may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pekka Anttila, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 39 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 28 | |
| 8 | 2021 | 7 | |
| 9 | 2018 | 25 | |
| 10 | 2016 | 8 | |
| 11 | 2015 | 30 | |
| 12 | Perinnöllinen makrotrombosytopenia ja kuulovika | 2015 | 1 |
| 13 | 2014 | 26 | |
| 14 | 2004 | 6 | |
| 15 | 2003 | 8 | |
| 16 | 2001 | 47 | |
| 17 | 1999 | 29 | |
| 18 | 1998 | 23 | |
| 19 | 1995 | 14 | |
| 20 | 1994 | 13 |
About Pekka Anttila
Pekka Anttila is a scholar working on Hematology, Genetics and Oncology, having authored 31 papers that have together received 404 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (8 papers), Cancer Treatment and Pharmacology (6 papers), Peptidase Inhibition and Analysis (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Platelet Disorders and Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Hematology (261 citations), Genetics (132 citations) and Oncology (129 citations). Pekka Anttila has collaborated with scholars based in Finland, Sweden and Denmark. Frequent co-authors include Eeva Juvonen, Raija Silvennoinen, Kalevi Oksanen, Tapani Ruutu, Esko Ikkala, Caroline A. Heckman, Muntasir Mamun Majumder, Nina N. Nupponen, Fredrik Lehmann and Kari Remes. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.